Connecticut Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
8,519
+333
+4% +$71.6K 0.08% 101
2026
Q1
$1.78M Buy
8,186
+19
+0.2% +$4.21K 0.07% 105
2025
Q4
$1.87M Buy
8,167
+1,125
+16% +$256K 0.08% 107
2025
Q3
$1.63M Buy
7,042
+3,033
+76% +$618K 0.07% 114
2025
Q2
$744K Sell
4,009
-10,115
-72% -$1.88M 0.04% 180
2025
Q1
$2.17M Buy
14,124
+10,413
+281% +$2.02M 0.11% 86
2024
Q4
$660K Buy
3,711
+57
+2% +$10.5K 0.03% 166
2024
Q3
$722K Buy
3,654
+1,492
+69% +$278K 0.03% 188
2024
Q2
$371K Buy
2,162
+184
+9% +$30.5K 0.02% 241
2024
Q1
$360K Sell
1,978
-35
-2% -$6.03K 0.02% 251
2023
Q4
$312K Buy
2,013
+248
+14% +$36.2K 0.02% 264
2023
Q3
$263K Buy
1,765
+200
+13% +$29.4K 0.02% 246
2023
Q2
$211K Sell
1,565
-10
-0.6% -$1.47K 0.01% 251
2023
Q1
$251K Buy
+1,575
New +$241K 0.02% 219
2021
Q2
Sell
-2,580
Closed -$279K 193
2021
Q1
$279K Buy
2,580
+2
+0.1% +$214 0.03% 132
2020
Q4
$276K Buy
2,578
+2
+0.1% +$192 0.03% 157
2020
Q3
$226K Buy
+2,576
New +$243K 0.02% 182

Other funds holding ABBV

Connecticut Wealth Management's ABBV Position: Q2 2026 in Review

Connecticut Wealth Management increased its AbbVie (ABBV) stake by 4.1% in Q2 2026, buying an estimated $71.6K and bringing the position to 8,519 shares worth $2.14M. The position accounts for 0.08% of the portfolio, ranked #101.

Connecticut Wealth Management first reported a position in ABBV in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.17M in Q1 2025. 2,162 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Connecticut Wealth Management held 8,519 shares of AbbVie worth $2.14M as of Q2 2026.
  • Connecticut Wealth Management bought 333 AbbVie shares in Q2 2026, an estimated $71.6K.
  • AbbVie made up 0.08% of Connecticut Wealth Management's portfolio in Q2 2026, its #101 holding.
  • Connecticut Wealth Management first reported a position in AbbVie in Q3 2020 and has held it in 17 quarters since.
  • Connecticut Wealth Management's AbbVie position peaked at $2.17M in Q1 2025.
  • 2,162 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.